AI & Machine Learning

A new, AI-powered platform from Trust & Will offers free tools to solo attorneys, aiming to shift estate planning from a one-off task to a proactive relationship.

Avalon GloboCare regains Nasdaq compliance, but its future is being reshaped by a bold AI launch and a transformative merger that questions its identity.

At NRF 2026, HPE unveiled new fault-tolerant servers and AI-native networking to ensure every transaction is secure and every insight is actionable.

The strategic merger creates an end-to-end system connecting employee voice to business performance, challenging the competitive HR tech landscape.

Yesway's Texas expansion hits a new milestone, blending the iconic Allsup's burrito with crypto ATMs in a bold new vision for the convenience store.

FirmTech is taking its AI-powered sexual wellness wearables worldwide, betting on data to revolutionize men's health. But can it navigate global privacy hurdles?

A historic $100M C-PACE loan funds a massive AI campus in Kansas City's iconic Star building, merging green finance with high-tech urban renewal.

With a new name and a laser focus on its lead hemophilia A drug, Metagenomi Therapeutics signals a major shift from platform tech to clinical powerhouse.

Applied Brain Research secures seed funding to commercialize its TSP1 chip, promising private, real-time voice AI without the cloud for countless devices.

Manas AI gains unique access to Schrödinger's physics platform, uniting top minds and tech to slash drug development timelines. Is this the future?

With $6.5M CAD in new funding, Montréal's AI4Eyes is set to accelerate the global launch of its all-in-one diagnostic and treatment platform.

Miro launches AI Workflows, aiming to transform team collaboration by making AI a visual partner on its canvas, promising to slash project times.

New 2025 data reveals an AI platform is slashing costs, improving chronic disease outcomes, and closing health equity gaps for hundreds of clinicians.

As McGraw Hill execs prep for a key investor conference, all eyes are on their digital-first strategy and how they'll navigate the AI-driven EdTech boom.

MediKarma is licensing autonomous AI agents to manage disease and data, aiming to become the core processor for the entire healthcare industry.

With a new board member and strategic investment, Kandu, Inc. is set to scale its brain-computer interface technology for stroke recovery.

VisionWave Holdings launches a major joint venture with Israeli partner AIPHEX, integrating AI, quantum tech, and a key financial contract.

Offerpad raises $18M in a direct offering. The move aims to bolster its finances and fund a strategic pivot to asset-light services in a changing market.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

Carlsmed's AI-driven aprevo® platform shows massive surgeon adoption and market growth, signaling a new era of personalized, cost-effective spine care.